FK506 restores sensitivity of thymic lymphomas to calcium-mediated apoptosis and the inducible expression of fas ligand

Anticancer Research

Volumn 23, Issue 2 B, 2003, Pages 1613-1617

  Kalas, Wojciech ^a   Matuszyk, Janusz ^a   Ziolo, Ewa ^a   Strzadala, Leon ^a  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Apoptosis; Calcium mediated; FK506; HA1004; Thymic lymphoma

Indexed keywords

ANTINEOPLASTIC AGENT; CALCINEURIN INHIBITOR; CALCIUM; ETOPOSIDE; FAS ANTIGEN; FAS LIGAND; IMMUNOSUPPRESSIVE AGENT; IONOMYCIN; N (2 GUANIDINOETHYL) 5 ISOQUINOLINESULFONAMIDE; TACROLIMUS;

ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CONTROLLED STUDY; DRUG EFFECT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; THYMUS LYMPHOMA;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CALCINEURIN; CALCIUM SIGNALING; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; ETOPOSIDE; FAS LIGAND PROTEIN; GENE EXPRESSION REGULATION, NEOPLASTIC; IONOMYCIN; IONOPHORES; ISOQUINOLINES; LYMPHOMA; MEMBRANE GLYCOPROTEINS; MICE; MICE, TRANSGENIC; NEOPLASM PROTEINS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, STEROID; SULFONAMIDES; TACROLIMUS; THYMUS NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0037900544     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Strzadala L, Miazek A, Matuszyk J and Kisielow P: Role of thymic selection in the development of thymic lymphomas in TCR transgenic mice. Int Immunol 9: 127-138, 1997.
2. Ulyanova T, Blasioli J and Thomas ML: Regulation of cell signaling by the protein tyrosine phosphatases, CD45 and SHP-1. Immunol Res 16: 101-113, 1997.
3. Lanier LL: Face off - the interplay between activating and inhibitory immune receptors. Current Opinion in Immunol 13: 326-331, 2001.
4. Ramirez De Molina A and Rodriguez-Gonzales A: Targeting new anticancer drugs within signaling pathways regulated by the Ras GTPase superfamily. Int J Oncol 19: 5-17, 2001.
5. 2+-mediated apoptosis through a protein kinase A-independent mechanism. Int Immunopharmacol 2: 435-442, 2002.
6. Evan GI and Vousden KH: Proliferation, cell cycle and apoptosis in cancer. Nature 411: 342-348, 2001.
7. Krammer PH: CD95's deadly mission in the immune system. Nature 407: 789-795, 2000.
8. Matuszyk J, Kobzdej M, Ziolo E, Kalas W, Kisielow P and Strzadala L: Thymic lymphomas are resistant to Nur77-mediated apoptosis. Biochem Biophys Res Commun 249: 279-282, 1998.
9. Kalas W, Kisielow P and Strzadala L: Inhibition of MEK induces Fas expression and apoptosis in lymphomas overexpressing Ras. Leukemia and Lymphoma 43: 1469-1474, 2002.
10. Kobzdej M, Matuszyk J and Strzadala L: Overexpression of Ras, Raf and L-myc but not Bcl-2 family proteins is linked with resistance to TCR-mediated apoptosis and tumorigenesis in thymic lymphomas from TCR transgenic mice. Leukemia Res 24: 33-38, 2000.
11. Kisielow P, Bluthmann H, Staerz UD, Steinmetz M and von Boehmer H: Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes. Nature 333: 742-746, 1988.
12. Nicoletti L, Migliorati G, Pagliacci M, Grignani F and Ricardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139: 271-279, 1991.
13. Matuszyk J, Kalas W, Cebrat M and Strzadala L: High expression of endogenous Bcl-2 and Bcl-xL in thymic lymphomas does not diminish their sensitivity to etoposide-induced apoptosis. Anticancer Res 21: 2677-2680, 2001.
14. Siitonen T, Mantymaa P, Savolainen E and Koistinen P: Etoposide-induced apoptsis is not associated with the Fas pathway in acute myeloblastic leukemia cells. Leukemia Res 24: 281-288, 2000.
15. Mo Y-Y and Beck WT: DNA damage signals induction of Fas ligand in tumor cells. Molecular Pharmacol 55: 216-222, 1999.
16. Mandic A, Victorsson K, Heiden T, Hansson J and Shoshan MC: The MEK1 inhibitor PD9809 sensitizes C8161 melanoma cells to cisplatin-induced apoptosis. Melanoma Res 11: 11-19, 2001.